Home Products Phagestaph

Phagestaph

Contact information

Sector
Chemicals & Pharmaceutics
Subsector
Pharmaceutical production
Description
Phagestaph (20ml x 4) is used for treatment and prevention of purulent-inflammatory diseases caused by Staphylococcus aureus (including MRSA - Multi-resistant Staphylococcus aureus).
Theurapeutic Indications: Preparation is used for the treatment and prevention of bacterial purulent-inflammatory infections, caused by Staphylococcus aureus in all ages and high risk groups:
Surgery: purulent wound, burns, abscess, phlegmon, furuncles, carbuncles, hidradenitis, panaritium, paraproctitis, mastitis, bursitis, osteomyelitis;
Urology:urogenital infections: urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis;
Gastroenterology: enterocolitis, cholecystitis, Irritable bowel syndrome (IBS-dysbiosis);
Bacterial infections of the upper and lower respiratory tract, inflammation of the sinuses, otisis media, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleuritis.
For detailed product information, annotation and registration certificate please visit the following page:
https://biochimpharm.ge/en/product/phagestaph-4x-20ml/
Shelf life: 2 years from the date of production
Levan Gotua 3
+995599411441
sales@biochimpharm.ge
https://biochimpharm.ge/

Products

website.video_/_photo_gallery

Product preparation
Logistics
Trade Agreements
Obtain Financing
Exhibition Calendar

Statistics

Exporters Guide

Online Training

Online Chat
×